Supplementary Table 1 for Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration’s September 1,2021, data safety communication
收藏Mendeley Data2026-04-09 收录
官方服务：
资源简介：
Supplementary Table 1 for Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration’s September 1,2021, data safety communication.
提供机构：
Jonathan Rick
